Skip to content
healthcare.dev

Tacrolimus

NDC 85972-103, Tacrolimus, capsule, from Stellon Biotech Inc..

Product NDC
85972-103
Status
Listed
Labeler
Stellon Biotech Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213112
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85972-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TACROLIMUS5 mg/1

Pharmacologic classes

Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]

Package NDCNDC-11Package
85972-103-0185972010301100 CAPSULE in 1 BOTTLE (85972-103-01)
85972-103-308597201033030 CAPSULE in 1 BOTTLE (85972-103-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b89e8a4-9f11-42e3-8e79-fe617e7c461f
  • NADAC price for package 85972010301

    GET /v1/drugs/nadac/85972010301

Use it

Look up 85972-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85972-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85972-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.